Patent classifications
B01D15/363
Permeative amine or acid introduction for very weak acid detection in ion chromatography
A permeative amine/acid introduction device (PAID) is placed after a conventional KOH eluent suppressed conductometric anion chromatography (SCAC) system. The PAID converts the suppressed eluites from the acid form to the corresponding salt. For example, when the analytes are acids, they are converted to the corresponding ammonium salt (NR.sub.2H+HX.fwdarw.NR.sub.2H.sub.2.sup.++X.sup.−) and allows very weak acids HX (pK.sub.a≥7.0) that cannot normally be detected by SCAC to be measured by a second conductivity detector following the PAID. Permeative reagent introduction is dilutionless, can be operated without pumps and provides good mixing with low band dispersion (as small as 30 μL). An exemplary amine is diethylamine (DEA), which was chosen as the amine source due to its low pK.sub.b value (pK.sub.b 3.0), high vapor pressure, and low toxicity and low odor.
POLYPHENOL COMPOSITIONS AND SUGARS INCLUDING VINASSE AND/OR DIGESTATE AND METHODS OF THEIR PREPARATION
The present invention provides a polyphenol composition comprising sugarcane bagasse and/or sugarcane vinasse. Methods of lowering the odour of the polyphenol composition using activated carbon. Methods of preparing the polyphenol composition following fermentation and distillation of a sugarcane derived product. Sugars and foods/beverages comprising the polyphenol composition and methods of preparing those.
SEPARATION MEDIA AND PURIFICATION METHODS FOR NUCLEOTIDES AND NUCLEOTIDE COMPONENTS USING THE SAME
Separation media includes a membrane and a plurality of ligands immobilized on the membrane, the plurality of ligands comprising anion-exchange ligands, cation-exchange ligands, thiophilic ligands, hydrophilic ligands, hydrophobic interaction ligands, or a combination thereof. The separation media may be multimodal. The separation media may be configured for separation of target molecules comprising a nucleic acid, nucleotide, nucleoside, nucleobase, or an analogue or derivative thereof, from a reaction mixture. The separation media may be configured for use with organic solvents. A separation device includes the separation media. Materials including a nucleic acid, nucleotide, nucleoside, nucleobase, or an analogue or derivative thereof, may be purified at high speeds using the separation device.
ENHANCED PURIFICATION OF ADENO-ASSOCIATED VIRUS TO MORE EFFECTIVELY REMOVE CONTAMINATING DNA
A method for reducing a contaminating DNA content of a preparation containing AAV capsids and contaminating DNA, comprising the steps of a) Performing an extraction of DNA with a solid phase bearing positive charges at its surface said solid phase is contacted with the preparation at a pH of 7.0±1.0, and a salt concentration of 10 mM to 200 mM yielding a first fraction, (b) Diafiltering the first fraction by a first tangential flow filtration to obtain a second fraction, (c) Treating the second fraction with DNase, (d) Diafiltering the DNase treated second fraction obtained by step c) by a second tangential flow, (e) filtration to a buffer with pH of 7.0±1.0, and a salt concentration of 10 mM to 20 mM to yield a third fraction, and optionally (f) Concentrating the third fraction by tangential flow filtration before supplemental chromatography.
Method for separation of radioactive sample using monolithic body on microfluidic chip
The present invention relates to monolithic bodies, uses thereof and processes for the preparation thereof. Certain embodiments of the present invention relate to the use of a monolithic body in the preparation of a radioactive substance, for example a radiopharmaceutical, as part of a microfluidic flow system and a process for the preparation of such a monolithic body.
Column-based fully scalable rAAV manufacturing process
In accordance with the invention, provided herein are methods for purifying recombinant adeno-associated (rAAV) vector particles.
Column-based fully scalable rAAV manufacturing process
In accordance with the invention, provided herein are methods for purifying recombinant adeno-associated (rAAV) vector particles.
MIXTURE OF BRANCHED SECONDARY ALCOHOL ETHOXYLATES FOR REMOVAL OF ENDOTOXINS IN ANION EXCHANGE CHROMATOGRAPHY
Provided herein is a method to reduce the endotoxin contamination in plasmid preparations. In the described method, plasmid DNA and endotoxins are bound to an anionic exchange matrix and are brought into contact with a wash buffer, comprising a combination of branched secondary alcohol ethoxylates with varying ethylene oxide chain lengths, wherein the branched secondary alcohol ethoxylates with the shorter ethoxylate chain is present in the washing buffer in excess compared to the branched secondary alcohol ethoxylate with the longer ethoxylate chain. The resulting purified plasmid has minimal endotoxin contamination levels and is considered endotoxin-free. Furthermore, provided are wash buffers comprising a combination of branched secondary alcohol ethoxylates with varying ethylene oxide chain lengths, kits comprising such wash buffers and the use of such wash buffers for reducing the endotoxin contamination in plasmid preparations.
ANALYTICAL METHOD FOR SUGAR CHAINS HAVING ACIDIC GROUPS
A chromatography column for the use of separation of acidic sugar chains, wherein the column comprises a first column and a second column, the second column connected by a flow path downstream of an outlet of the first column, and selected from the following (1) or (2): (1) the carrier of the first column is hydrophobically modified silica having a group containing a primary amine, a secondary amine or/and a tertiary amine, and the carrier of the second column is a resin having a group containing a primary amine, a secondary amine or/and a tertiary amine; (2) the carrier of the first column is a resin having a group containing a primary amine, a secondary amine or/and a tertiary amine, and the carrier of the second column is hydrophobically modified silica having a group containing a primary amine, a secondary amine, or/and a tertiary amine.
STEVIOL GLYCOSIDE MALONIC ACID ESTERS
Various embodiments disclosed relate to steviol glycoside malonic acid esters (SGMAs). The present invention provides one or more SGMAs or salts thereof, compositions including the one or more SGMAs or salts thereof, and methods of forming a composition that includes one or more steviol glycoside malonic acid esters (SGMAs) or salts thereof. A composition including one or more SGMAs or salts thereof can be a sweetener or a sweetened composition such as a beverage concentrate, a sweetened beverage, a carbonated soft drink, a solid food stuff, a pharmaceutical composition, a nutritional supplement, or a dental composition.